Neurocrine Obtains Exclusive Rights For Depression Drug, Takeda Reacquires Japan Rights

cryptocurrency 2 weeks ago
Flipboard
On Monday, Neurocrine Biosciences, Inc. (NASDAQ:NBIX) amended its agreement with Takeda Pharmaceutical Co Ltd (NYSE:TAK) to develop and commercialize …
Read Entire Article